🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Pediatric Intestinal Failure

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site📍 Pittsburgh Paul Szabolcs · Tests: data collection Weaning is Winning? (WeWin Study) NCT06525753n/a1 site📍 Toronto The Hospital for Sick Children · Tests: Weaning off Parenteral Nutrition Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial NCT06699433NA3 sites📍 Guiyang📍 Fuzhou📍 Yisa Southern Medical University, China · Tests: Virtual standardized patients (VSPs), Case teaching manuals, Case teaching videos Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure NCT04629014n/a14 sites📍 Birmingham📍 Aurora📍 Hartford Boston Children's Hospital KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure NCT05879835NA8 sites📍 Boston📍 Omaha📍 New York SterileCare Inc. · Tests: KiteLock 4% Sterile Catheter Lock Solution, Heparin Lock Solution VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients NCT07202910n/a1 site📍 Gothenburg Sahlgrenska University Hospital Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome NCT05535361NA5 sites📍 Palo Alto📍 San Francisco📍 Washington D.C. Eclipse Regenesis, Inc. · Tests: Distraction Enterogenesis in Adult Patients with Short Bowel Syndrome
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy